Revolution Medicines, Inc. (RVMD)
149.67
+1.18
(+0.79%)
USD |
NASDAQ |
Jun 09, 16:00
149.67
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines SG&A Expense (Quarterly) : 101.25M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Erasca, Inc. | 10.65M |
| Tango Therapeutics, Inc. | 15.24M |
| Kymera Therapeutics, Inc. | 20.36M |
| Replimune Group, Inc. | 18.73M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |